Calunod, Shinny .
HRN: 22-32-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
CEFUROXIME 500MG (TAB)
05/04/2023
05/11/2023
PO
500 Mg
BID X 7 Days
S/P Nsvd With Episiorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes